Summary
Based on a review of the pathophysiology of the major symptoms of anorexia nervosa, it was suggested that increased activity of dopamine at central dopamine receptors plays a role in the pathophysiology of this disorder. Although dopamine receptor site hypersensitivity, or synthesis, of a false transmitter could account for this, a defect in negative feedback control mechanisms is more consistent with the known characteristics of anorexia nervosa. The possible role of pure dopamine antagonists in symptomatic treatment and of dopamine agonists in reversing this disorder was discussed.
Similar content being viewed by others
References
Anden, N.-E.: Pharmacological and anatomical implications of induced abnormal movements with L-dopa. In: L-dopa and Parkinsonism (Barbeau, A., McDowell, F. H., eds.), pp. 132–143. Philadelphia: F. A. Davis. 1970.
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol.19, 627 to 629 (1967).
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol.11, 303–314 (1970).
Baez, L. A.: Role of catecholamines in the anorectic effects of amphetamine in rats. Psychopharmacologia35, 91–98 (1974).
Baldessarini, R. J.: Pharmacology of the amphetamines. Pediatrics49, 694 to 700 (1972).
Barbeau, A., Mars, H., Gillo-Joffroy, L.: Adverse clinical side effects of levodopa therapy. In: Recent Advances in Parkinson's Disease (Barbeau, A., McDowell, F. H., eds.). Philadelphia: F. A. Davis. 1971.
Barnett, A., Goldstein, J., Taber, R. I.: Apomorphine-induced hypothermia in mice, a possible dopaminergic effect. Arch. Int. Pharmacodyn. Ther.198, 242–247 (1972).
Barzaghi, F., Groppetti, A., Mantegazza, P., Muller, E. F.: Reduction of food intake by apomorphine: A pimozide sensitive effect. J. Pharm. Pharmacol.25, 909–911 (1973).
Bell, D. S.: Comparison of amphetamine psychosis and schizophrenia. Br. J. Psychiatry111, 701–707 (1965).
Bell, D. S., Trethowan, N.: Amphetamine addiction and disturbed sexuality. Arch. Gen. Psychiatry4, 74–78 (1961).
Beumont, P. J. V.: Anorexia nervosa in male subjects. Psychother. Psychosom.18, 365–371 (1970).
Beumont, P. J. V., Carr, P. J., Gelder, M. G.: Plasma levels of luteinizing hormone and of immuno-reactive oestrogens (oestradiel) on anorexia nervosa: Response to clomiphene citrate. Psychol. Med.3, 495–501 (1973).
Bliss, E. L., Branch, C. H.: Anorexia Nervosa. Psychosomatic Medicine Monograph 14. New York: Hoeber. 1960.
Bobon, D. P., Janssen, P. A. J., Bobon, J.: The Neuroleptics. Modern Problems of Pharmapsychiatry. Basel: Karger. 1970.
Boyar, R. M., Katz, J., Finkelstein, J. W., Kapen, S., Weiner, H., Weitzman, E. D., Hellman, L.: Anorexia nervosa: Immaturity of the 24-hour leuteinizing hormone secretory pattern. N. Engl. J. Med.291, 861–865 (1974).
Bruch, H.: Anorexia nervosa and its differential diagnosis. J. Nerv. Ment. Dis.141, 555–566 (1966).
Bruch, H.: Anorexia nervosa in the male. Psychosom. Med.33, 31–47 (1971).
Carlsson, A.: Biochemical implications of dopa-induced actions on the central nervous system, with particular reference to abnormal movements. In: L-dopa and Parkinsonism (Barbeau, A., McDowell, F. H., eds.), pp. 205–213. Philadelphia: F. A. Davis. 1970.
Cole, S. O.: Hypothalamic feeding mechanisms and amphetamine anorexia. Psychol. Bull.79, 13–20 (1973).
Corrodi, H., Fuxe, K., Ungerstedt, U.: Evidence for a new type of dopamine receptor stimulating agent. J. Pharm. Pharmacol.23, 989–991 (1971).
Corrodi, H., Garnebo, L.-O., Fuxe, K., Hamberger, B., Ungerstedt, U.: ET-495 and brain catecholamine mechanisms: Evidence for a stimulation of central dopamine neurons. Eur. J. Pharmacol.20, 195–204 (1972).
Crisp, A. H., Toms, D. A.: Primary anorexia nervosa or weight phobia in the male: Report on 13 cases. Br. Med. J.1, 334–338 (1972).
Dally, P. J.: Anorexia Nervosa. London: Heinemann. 1969.
Danowski, T. S., Livstone, E., Gonzales, A. R., Jung, Y., Khurana, R. C.: Fractional and partial hypopituitarism in anorexia nervosa. Hormones5, 105–118 (1972).
Editors: Anorexia nervosa. Br. Med. J.4, 183–184 (1971).
Ellinwood, E. H. J.: Amphetamine psychosis. I. Description of the individuals and the process. J. Nerv. Ment. Dis.144, 273–283 (1967).
Ellinwood, E. H. J.: Amphetamine psychosis. II. Theoretical implications. Int. J. Neuropsychiatry4, 45–54 (1968).
Ellinwood, E. H. J.: Amphetamine psychosis: A multi-dimensional process. Semin. Psychiatry1, 208–226 (1969).
Ellinwood, E. H. J., Sudilovsky, A., Nelson, L. M.: Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am. J. Psychiatry130, 1088–1093 (1973).
Ernst, A. M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia10, 316–323 (1967).
Frazier, S. H.: Anorexia nervosa. Dis. Nerv. Syst.26, 155–159 (1965).
Fuxe, K.: Tools in the treatment of Parkinson's disease: Studies on new types of dopamine receptor stimulating agents. In: Progress in the Treatment of Parkinsonism (Calne, D. B., ed.). New York: Raven Press. 1973.
Fuxe, K., Sjoqvist, F.: Hypothermic effect of apomorphine in the mouse. J. Pharm. Pharmacol.24, 702–705 (1972).
Fuxe, K., Hökfelt, T., Jonsson, G.: Participation of central monoaminergic neurons in the regulation of anterior pituitary secretion. In: Neurochemical Aspects of Hypothalamic Function (Martini, L., Meites, J., eds.), pp. 61–83. London: Academic Press. 1970 a.
Fuxe, K., Hökfelt, T., Ungerstedt, U.: Morphological and functional aspects of central monoamine neurons. In: International Review of Neurobiology (Pfeiffer, C. C., Smythies, J., eds.), pp. 93–126. New York: Academic Press. 1970 b.
Fuxe, K., Agnati, L. F., Corrodi, H., Everitt, B. J., Hökfelt, T., Lofstrom, A., Ungerstedt, U.: Action of dopamine receptor agonists in forebrain and hypothalamus: Rotational behavior, ovulation, and dopamine turnover. In: Advances in Neurology, Vol. 9 (Calne, D. B., Chase, T. N., Barbeau, A., eds.), pp. 223–242. New York: Raven Press. 1975.
Greaves, G.: Sexual disturbances among chronic amphtamine users. J. Nerv. Ment. Dis.155, 363–365 (1972).
Gull, W. W.: The address in Medicine delivered before the Annual Meeting of the British Medical Association at Oxford, Vol.2, pp. 171–176 (1868).
Hart, T., Kase, N., Kimball, C. P.: Induction of ovulation and pregnancy in patients with anorexia nervosa. Am. J. Obstet. Gynecol.108, 508 to 584 (1970).
Hökfelt, T., Fuxe, K.: On the morphology and neuroendocrine role of the hypothalamic catecholamine neurons. In: Brain-Endocrine Interaction. Median Eminence: Structure and Function (Knigge, M., ed.). New York: A. J. Phiebig. 1972.
Johansson, A. J., Knorr, N. J.: Treatment of anorexia nervosa by levodopa. Lancet2, 591 (1974).
Kay, D. W. K., Leigh, D.: The natural history, treatment, and prognosis of anorexia nervosa, based on a study of 38 patients. J. Ment. Sci.100, 411–431 (1954).
Kidd, C. B., Wood, J. F.: Some observations on anorexia nervosa. Postgrad. Med. J.42, 443–448 (1966).
Klawans, H. L.: The pharmacology of tardive dyskinesias. Am. J. Psychiatry130, 82–86 (1973).
Klawans, H. L., Margolin, D. I.: Amphetamine-induced hypersensitivity in guinea pigs (implications in psychosis and human movement disorders). Arch. Gen. Psychiatry32, 725–732 (1975).
Klawans, H. L., Shenker, D. M.: Observations on the dopaminergic nature of hyperthyroid chorea. J. Neural Transm.33, 73–81 (1972).
Klawans, H. L., Weiner, W. J.: Animal models of human extrapyramidal disorders. In: Models of Human Neurological Diseases (Klawans, H. L., ed.), pp. 5–38. Amsterdam: Excerpta Medica. 1974.
Klawans, H. L., Ilahi, M. M., Ringel, S. P.: Toward an understanding of the pathophysiology of Huntington's chorea. Confin. Neurol.33, 297–303 (1971).
Klawans, H. L., Goetz, C. C., Westheimer, R.: Pathophysiology of schizophrenia and the striatum. Dis. Nerv. Syst.33, 714–719 (1973).
Klawans, H. L., Westheimer, R., Goetz, C. C.: A pharmacological model of the pathophysiology of schizophrenia. Dis. Nerv. Syst.36, 267–275 (1975).
Lakoff, K. M., Feldman, J. D.: Anorexia nervosa associated with pregnancy. Obstet. Gynecol.39, 699–701 (1972).
Lapin, I. P., Samsonova, M. L.: Apomorphine induced hypothermia in mice and the effect thereon of adrenergic and serotonergic agents. Farmakol. Toksikol.31, 563 (1968).
Lundberg, P. O., Walinder, J. M., Werner, I., Wide, L.: Effects of thyrotorphin-releasing hormone on plasma levels of TSH, FSH, LH, and GH in anorexia nervosa. Eur. J. Clin. Invest.2, 150–153 (1972).
McCann, S. M., Kalra, P. S., Donoso, A. O., Bishop, W., Schneider, H. P. G., Fawcett, D. P., Krulich, L.: The role of monoamines in the control of gonadotrophin and prolactin secretion. In: Brain-Endocrine Interaction. Median Eminence: Structure and Function (Knigge, M., ed.), pp. 224 to 235. New York: A. J. Phiebig. 1972.
Marshall, J. C., Fraser, T. R.: Amenorrhea in anorexia nervosa: Assessment and treatment with clomiphene citrate. Br. Med. J.4, 590–592 (1971).
Mecklenburg, R. S., Loriaux, D. L., Thompson, R. H., Andersen, A. E., Lipsett, M. B.: Hypothalamic dysfunction in patients with anorexia nervosa. Medicine (Baltimore)53, 147–159 (1974).
Meyerson, B. J.: Monoamines and hormone activated oestrus behavior in the ovariectomized hamster. Psychopharmacologia18, 50–57 (1970).
Russell, G. F. M., Beardwood, C. J.: Amenorrhea in the feeding disorders: Anorexia nervosa and obesity. Psychother. Psychosom.18, 359–364 (1970).
Russell, G. F. M., Loraine, J. A., Bell, E. T., Harkness, R. A.: Gonadotrophin and estrogen excretion in patients with anorexia nervosa. J. Psychosom. Res.9, 79–85 (1965).
Rylander, G.: Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. Psychiatr. Neurol. Neurochir.75, 203–212 (1972).
Seidensticker, J. F., Tzagournis, M.: Anorexia nervosa-clinical features and long-term follow-up. J. Chronic Dis.21, 361–367 (1968).
Snyder, S. H.: Catecholamines in the brain as mediators of amphetamine psychosis. Arch. Gen. Psychiatry27, 169–179 (1972).
Starkey, F. A., Lee, R. A.: Menstruation and fertigility in anorexia nervosa. Am. J. Obstet. Gynecol.105, 374–379 (1969).
Stevens, J. R.: An anatomy of schizophrenia. Arch. Gen. Psychiatry29, 177–189 (1973).
Theander, S.: Anorexia nervosa. Acta Psychiatr. Scand. (Suppl.)214, 1 (1970).
Vemura, H., Kobayashi, H.: Effects of dopamine implanted in the median eminence on the estrous cycle of the rat. Endocrinol. Japan18, 91–100 (1971).
Wakeling, A., Russell, G. F. M.: Disturbances in regulation of body temperature in anorexia nervosa. Psychol. Med.1, 30–39 (1970).
Warren, M. P., van de Wiele, R. L.: Clinical and metabolic features of anorexia nervosa. Am. J. Obstet. Gynecol.117, 435–449 (1973).
Wiegelmann, W., Solbach, H. G.: Effects of LH-RF on plasma levels of LH and FSH in anorexia nervosa. Horm. Metab. Res.4, 404 (1972).
Weiner, R. I., Gorski, R. A., Sawyer, C. H.: Hypothalamic catecholamines and pituitary gonadotrophic function. In: Brain-Endocrine Interaction. Median Eminence: Structure and Function (Knigge, M., ed.), pp. 236 to 244. New York: A. J. Phiebig. 1972.
Yehuda, S., Wurtman, R. J.: Release of brain dopamine as the probable mechanism fore the hypothermic effect of d-amphetamine. Nature (Lond.)240, 477–478 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barry, V.C., Klawans, H.L. On the role of dopamine in the pathophysiology of anorexia nervosa. J. Neural Transmission 38, 107–122 (1976). https://doi.org/10.1007/BF01262969
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01262969